Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway

Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway

We evaluated the effect of isoquercetin (quercetin-O-3-glucoside-quercetin, IQ) as a functional component of Abeliophyllum disistichum Nakai ethanol extract (ADLE) on prostate cell proliferation and apoptosis and its effects on the IGF-1/PI3K/Akt/mTOR pathway in benign prostatic hyperplasia (BPH). M...

Full description

Saved in:

Bibliographic Details
Main Authors:	Young-Jin Choi, Meiqi Fan, Nishala Erandi Wedamulla, Yujiao Tang, Eun-Kyung Kim
Format:	Article
Language:	English
Published:	Tsinghua University Press 2024-05-01
Series:	Food Science and Human Wellness
Subjects:	isoquercetin benign prostatic hyperplasia androgen receptor signaling pi3k/akt/mtor pathway
Online Access:	https://www.sciopen.com/article/10.26599/FSHW.2022.9250216
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Investigating mTOR signaling pathway and sirolimus response in Benign lymphangioendothelioma
by: Xin Wen, et al.
Published: (2025-12-01)

Hovenia dulcis Honey Suppresses Androgen‐Induced Epithelial–Mesenchymal Transition in Benign Prostatic Hyperplasia
by: Buyun Kim, et al.
Published: (2025-05-01)

Benign prostatic hyperplasia and periodontitis
by: YANG Shisong, et al.
Published: (2024-03-01)

Euodia rutaecarpa fruit attenuates testosterone-induced benign prostatic hyperplasia in rats by inhibiting 5α-reductase activity and androgen receptor signaling pathway
by: Yung Hyun Choi
Published: (2024-11-01)

Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01)

Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01)

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
by: O.O. Sherstyuk, et al.
Published: (2022-08-01)

mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node
by: Laura Mantoan Ritter, et al.
Published: (2025-05-01)

The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01)

The influence of metabolic syndrome on the development and clinical manifestations of benign prostatic hyperplasia
by: V. B. Filimonov, et al.
Published: (2018-12-01)

Meta-analysis of Acupuncture Intervening Benign Prostatic Hyperplasia
by: Xueyuan Yang, et al.
Published: (2025-03-01)

Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
by: Taofiq Olayinka Mohammed, et al.
Published: (2024-12-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)

Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats
by: Sung-Ok Kim, et al.
Published: (2025-01-01)

AKT/mTOR信号通路在喉癌组织中的表达及意义
Published: (2009-01-01)

Prevalence of benign prostatic hyperplasia and prostrate cancer among suburban residents in Southern Nigeria
by: Ugochukwu Esomonu, et al.
Published: (2024-12-01)

Identification of an intestinal microbiota enterotypes in ageing man diagnosed with benign prostatic hyperplasia (BPH)
by: Weronika Ratajczak-Zacharko, et al.
Published: (2025-05-01)

The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia
by: QIAN Xinhang, et al.
Published: (2024-02-01)

OPTIMIZATION OF TREATMENT AND PROGNOSTIC APPROACHES TO BENIGN PROSTATIC HYPERPLASIA COMPLICATIONS
by: S. M. Pikalov, et al.
Published: (2020-11-01)

Possibilities of Therapeutic and Prophylactic Tactics in Management of Benign Prostatic Hyperplasia in Tuberculosis Patients
by: Z. R. Rashidov, et al.
Published: (2021-08-01)

Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia
by: Stanislav N. Volkov, et al.
Published: (2024-01-01)

The effect of systemic hypertension on prostatic arterial hemodynamics in dogs with benign prostate hyperplasia
by: Çağatay ESİN
Published: (2024-11-01)

Negative impact of benign prostatic hyperplasia on fertility in dogs–a mini-review
by: Anna Domosławska-Wyderska, et al.
Published: (2025-05-01)

Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
by: Liujing Qu, et al.
Published: (2024-07-01)

Research on the role and mechanism of the PI3K/Akt/mTOR signalling pathway in osteoporosis
by: Chuanlong Liu, et al.
Published: (2025-05-01)

Laser technologies in surgery for benign prostate hyperplasia
by: S. A. Rakhimov, et al.
Published: (2024-03-01)

Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
by: Liujing Qu, et al.
Published: (2025-07-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

Urinary dysfunction in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia
by: S. Kh. Al-Shukri, et al.
Published: (2017-12-01)

Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives
by: Aris Kaltsas, et al.
Published: (2025-02-01)

Relationship and potential mechanisms between gut microbiota and benign prostatic hyperplasia
by: WANG Congcong, et al.
Published: (2024-05-01)

Identification and Characterization of Differentially Expressed MicroRNAs in Benign Prostatic Hyperplasia
by: Lingmin Song, et al.
Published: (2025-04-01)

Correlation of American Urological Association Symptom Index Domains with Uroflowmetric Peak Flow in Thai Patients with Suspected Benign Prostatic Hyperplasia
by: Sidaporn Chayochaichana, et al.
Published: (2024-11-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

Doppler Ultrasonography in the Diagnosis of Dogs With Benign Prostatic Hyperplasia and Investigation of the Efficacy of Finasteride in Treatment
by: Burcu Esin, et al.
Published: (2025-05-01)

The Activation of PI3K/AKT/mTOR Signaling Pathway in Response to Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer Cells
by: Işıl Ezgi Eryılmaz, et al.
Published: (2021-12-01)

Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway
by: Adrish Sen, et al.
Published: (2025-01-01)

Choice Of treatment method for symptomatic Bladder outlet obstruction in patients with benign prostatic hyperplasia after kidney transplantation
by: S. V. Popov, et al.
Published: (2023-07-01)

Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01)